Venture Capital/Consumer, fintech, deeptech, climate
Blume Ventures logo

Blume Ventures

Pre-seed to Series A fund research profile

Blume is an India-focused early-stage platform built around seed and pre-Series A investing, with a broad technology mandate rather than a single vertical. Its value-add model combines the fund with operating support in finance, legal, talent and market networks.

At a glance

Founded
2010
Footprint
Mumbai / Bengaluru
Stage
Pre-seed to Series A

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Blume Ventures uses a pre-seed to series a approach across Consumer, fintech, deeptech, climate.

Current evidence

Blume announced the initial close of Fund V at $175M in 2025, with named investments including Mave Health, Confido Health, Lucira Jewelry, OZi, PowerUp Money and iDO Devices; the GP also reports 2025 distributions above $80M.

Bundled fund series

Related manager and vehicle records are shown here as one fund family. The original source trails and vehicle-level caveats remain preserved in the research record.

Blume Ventures Fund V

Vintage / record year: 2025

Strategy

Pre-seed to Series A

Sector focus

Consumer, fintech, deeptech, climate

AIF structure context

Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.

Current signal

Blume announced the initial close of Fund V at $175M in 2025, with named investments including Mave Health, Confido Health, Lucira Jewelry, OZi, PowerUp Money and iDO Devices; the GP also reports 2025 distributions above $80M.

Investor questions

Blume Ventures research questions

What is Blume Ventures's investment strategy?

Blume Ventures is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Pre-seed to Series A, with a sector focus of Consumer, fintech, deeptech, climate. The profile should be read with the linked source trail and Typical route: Category I AIF context.

What portfolio evidence is available for Blume Ventures?

The profile displays only company or asset names attributable to Blume Ventures in the reviewed public sources: Purplle, Unacademy, Dunzo, GreyOrange, Slice, longest-running independent Indian seed fund (2010), Mave Health, Confido Health, Lucira, OZi, PowerUp Money, iDO Devices, BIDSO, Vectra Pay, Numero, Lumio, Ollive.ai, The GP’s Fund V page lists 12 investments at the time of review, the list is a current public snapshot, not a complete historical portfolio count.. It does not represent a complete current portfolio unless the manager has published one.

What is known about Blume Ventures's performance or track record?

Fund IV reporting cites category creators including Unacademy, Slice, smallcase, Purplle, Battery Smart, GreyOrange and LambdaTest. Blume’s Fund V update says the manager anticipated aggregate DPI above $80M across all funds in 2025; this is a forward-looking manager statement, not audited fund-level performance. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Blume Ventures's fund size, fees and minimum investment?

Public fund size: Fund IV is approximately $290M on the GP’s fund page. Fund V reached an initial close of $175M in October 2025 with a reported $250–275M final-close target; IFC described a $300M target for its GIFT Fund V project.. Public terms or access information: Pre-seed to Series A / early-stage investing in Indian and cross-border technology businesses. Blume’s Fund III page disclosed $750K–$2.3M cheques; current Fund V cheque terms are not fully disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Blume Ventures's investment team?

The current source record names Karthik Reddy, Sanjay Nath, Sajith Pai. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Blume Ventures?

Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Fund V close; fintech-specific exits (gap flagged VC-FT-001) Vehicle-level differences from Blume Ventures Fund V are retained in seriesRecords; the directory publishes one manager-level record..

What is the latest public update on Blume Ventures?

2025-10-29: Blume announced the initial close of Fund V at $175M in 2025, with named investments including Mave Health, Confido Health, Lucira Jewelry, OZi, PowerUp Money and iDO Devices; the GP also reports 2025 distributions above $80M.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →